300871.SZ深圳证券交易所 · 创业板 ChiNext
Wuhan HVSEN Biotechnology 回盛生物
Animal Health 动物保健Ⅱ
¥20.89−¥0.66 · −3.06%
Open 开盘
¥21.58
High 最高
¥21.66
Low 最低
¥20.85
Prev Close 昨收
¥21.55
Volume 成交量
334.0万股
Turnover 成交额
¥7,046.7万
Mkt Cap 总市值
¥42亿
P/E 市盈率
12.3×
Recent Activity 近期动态All Filings 全部公告 →
20 significant filings since 30 May 2026: 10 on buyback, 5 on guarantee or financial assistance and 3 on dividend, and 2 other kinds. The latest, on 9 Sep 2026: 关于控股股东、实际控制人之间内部转让股份计划的预披露公告.
自 30 May 2026 起有 20 份重大公告：buyback 10 份、guarantee or financial assistance 5 份、dividend 3 份，另有 2 类。最新一份（9 Sep 2026）：关于控股股东、实际控制人之间内部转让股份计划的预披露公告。
20.0022.5025.0027.5030.00
Volume 成交量
4,199.3万
Sep 25Dec 25Mar 26Jun 26Sep 26
Overview 概览Deep Report 深度报告Financials 财务Valuation 估值Ownership 股东Analysts 券商Estimates 预测News 动态Events 事件Peers 同业
Relative Value 同业比较
Animal Health 动物保健Ⅱ · 12 listed peers
| Measure 指标 | This Company 本公司 | Peer Median 同业中值 | Standing 排位 | |
|---|---|---|---|---|
| Market Cap 市值 | ¥42亿 | ¥39亿 | 6th highest of 12 · 12 家中第 6 高 | |
| Trailing P/E 市盈率 | 12.3x | 48.6x | Lowest of 9 · 9 家中第 1 低 | |
| P/B 市净率 | 1.8x | 2.1x | 6th lowest of 12 · 12 家中第 6 低 | |
| Revenue Growth 营收增速 | 5.2% | 0.0% | 4th highest of 12 · 12 家中第 4 高 | |
| Profit Growth 净利增速 | 75.6% | -36.2% | 2nd highest of 12 · 12 家中第 2 高 | |
| Gross Margin 毛利率 | 35.7% | 38.8% | 5th lowest of 12 · 12 家中第 5 低 | |
| Net Margin 净利率 | 23.9% | 8.3% | 2nd highest of 12 · 12 家中第 2 高 | |
| Return on Equity 净资产收益率 | 9.1% | 2.3% | 2nd highest of 12 · 12 家中第 2 高 | |
| Debt to Assets 资产负债率 | 31.8% | 23.4% | 5th highest of 12 · 12 家中第 5 高 | |
| Grade Score 评级得分 | 65 | 54 | Highest of 12 · 12 家中第 1 高 |
Statement figures are for the period to 30 Jun 2026, filed by 12 of 12 peers. A rank needs 5 or more peers with a value. A company with no earnings has no P/E. 报表数据为截至 30 Jun 2026 的期间，12 家同业中 12 家已披露。排位至少需要 5 家有数据的同业；无盈利的公司没有市盈率。
Largest Peers 主要同业
| Peer 同业 | Market Cap | P/E | P/B | Revenue Growth | Net Margin | ROE | Grade |
|---|---|---|---|---|---|---|---|
| Jinyu 生物股份 | ¥125亿 | 87.2x | 2.3x | 22.1% | 14.7% | 1.9% | C |
| Tianjin Ringpu Bio-Technology 瑞普生物 | ¥77亿 | 22.2x | 1.6x | 0.8% | 12.9% | 4.3% | C |
| China Animal Husbandry 中牧股份 | ¥68亿 | 48.6x | 1.2x | 13.5% | 2.3% | 0.9% | D |
| Keqian Biology 科前生物 | ¥57亿 | 18.1x | 1.4x | -23.3% | 30.7% | 2.8% | C |
| Jinhe Biotechnology 金河生物 | ¥43亿 | 210.0x | 1.7x | 4.1% | 9.3% | 5.7% | C |
| Wuhan HVSEN Biotechnology 回盛生物 | ¥42亿 | 12.3x | 1.8x | 5.2% | 23.9% | 9.1% | C |
| Pulike 普莱柯 | ¥35亿 | 24.1x | 1.4x | -12.2% | 13.0% | 3.0% | C |
| Lifecome Biochemistry 绿康生化 | ¥35亿 | — | 49.1x | -15.7% | 2.8% | 10.9% | C |
| Shen Lian Biomedical 申联生物 | ¥34亿 | — | 2.5x | -8.1% | -18.2% | -1.4% | D |
| Winsunbio 永顺生物 | ¥18亿 | 64.0x | 2.7x | -28.1% | 7.3% | 0.9% | D |
| Drive 驱动力 | ¥11亿 | 460.9x | 4.6x | -0.8% | -1.6% | -0.2% | D |
| Dayu Biological 大禹生物 | ¥6.96亿 | — | 2.9x | 15.7% | -36.9% | -10.6% | E |
Peers are listed by market cap, with this company highlighted. 同业按市值排列，本公司高亮显示。